Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +22.50%
#4 Bedrock Bedrock +19.73%
#5 Velvet Velvet +19.00%
#6 Fabric Protocol Fabric Protocol +16.39%
#7 Nockchain Nockchain +16.19%
#8 Perle Perle +13.72%
#9 Versatize Coin Versatize Coin +12.49%
#10 Starpower Starpower +12.07%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Classement en actions #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Prix de l'action
$0.00060315
Dernière synchronisation: 2024-09-27
Capitalisation boursière
$1.65M
Changement (1 jour)
19.64%
Changement (1 an)
0.00%
Pays
SE
Échange Amniotics AB (publ) (AMNI)

Catégorie

Healthcare
Ratio P/B pour Amniotics AB (publ) (AMNI)
Ratio P/B au August 2026 TTM : 0.98
Selon les derniers rapports financiers et le cours de l'action de Amniotics AB (publ), le ratio cours/valeur comptable actuel (TTM) est 0.98. À la fin de 2022, le ratio P/B était de 43.73.
Historique du ratio P/B pour Amniotics AB (publ) de 2018 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) 0.98 -40.17%
2023 1.63 -96.28%
2022 43.73 263.99%
2021 12.01 -34.02%
2020 18.21 -69.40%
2019 59.51 -75.80%
2018 245.87 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 550.32%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 540.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 254.92%
BE